Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 , a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease
TP-03 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
Oreterra Receives Conditional Approval to Sell Option to Buy Down Newmont Lake Royalty to Enduro Metals
Harvest Gold Announces Non-Brokered Private Placement To Fund 2026 Drill Program On Its Flagship Mosseau Property
